Vulcan Two Group Plc logo

Vulcan Two Group Plc (Y0U)

Market Open
12 Aug, 06:56
XFRA XFRA
2. 08
-0.08
-3.7037%
58.91M Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
2.16
Previous Close
Add Transaction
Day Range
2.08 2.08
Year Range
2.01 3.02
Want to track Y0U and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

Y0U trading today lower at €2.08, a decrease of -3.7037% from yesterday's close, completing a monthly decrease of -21.8045% or -€0.58. Over the past 12 months, Y0U stock lost -5.5833%.
Y0U is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

Y0U Chart

Vulcan Two Group Plc (Y0U) FAQ

What is the stock price today?

The current price is €2.08.

On which exchange is it traded?

Vulcan Two Group Plc is listed on XFRA.

What is its stock symbol?

The ticker symbol is Y0U.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 58.91M.

Has Vulcan Two Group Plc ever had a stock split?

No, there has never been a stock split.

Vulcan Two Group Plc Profile

- Industry
- Sector
Mr. Michael Benjamin Kraftman CEO
XFRA Exchange
- ISIN
United Kingdom Country
6 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Vulcan Two Group Plc is a United Kingdom-based investment company established in August 2025, focusing on the acquisition and development of companies within the ePharmacy market. As a public limited company, it operates under the venture and development capital model, aiming to identify and consolidate businesses that emphasize digital pharmacy services and related healthcare technology solutions. The company's registration is in London, and it trades on the London Stock Exchange, providing investors with opportunities to engage with the rapidly expanding ePharmacy sector. This sector includes online pharmaceutical services, telemedicine integration, and digital health platforms.

Vulcan Two Group Plc is strategically positioned to take advantage of the structural changes in healthcare delivery trends, particularly the growing consumer acceptance of online pharmacy services. The acquisition-centric strategy allows the company to enhance value through consolidation and operational improvements in a fragmented ePharmacy landscape, aiming to drive innovation and efficiency in this vital segment of the healthcare industry.

Products and Services

  • ePharmacy Acquisition: Vulcan Two Group Plc specializes in acquiring established ePharmacy businesses to expand its operational footprint in the digital pharmacy market. This includes targeting companies that offer innovative online pharmaceutical services.
  • Healthcare Technology Solutions: The company invests in businesses that develop advanced healthcare technologies, integrating platforms that facilitate telemedicine and enhance patient care through digital means.
  • Telemedicine Services: By investing in telemedicine solutions, Vulcan Two Group Plc enhances the accessibility of healthcare, allowing consumers to receive medical consultations remotely and conveniently through digital channels.
  • Digital Health Platforms: The company identifies opportunities within digital health platforms that provide users with tools to manage their health, track medications, and access professional health advice through convenient online interfaces.
  • Consolidation Strategies: Vulcan Two Group Plc employs a consolidation approach to integrate and streamline operations of acquired businesses, improving efficiencies and creating synergies across its portfolio.
  • Value Creation Initiatives: The company actively works on initiatives aimed at enhancing the value of its acquired companies through operational improvements, implementing best practices, and fostering innovation in service delivery.

Contact Information

Address: 201 Temple Chambers
Phone: 44 20 7583 8304